DrugPatentWatch Database Preview
Details for Patent: 7,816,396
Which drugs does patent 7,816,396 protect, and when does it expire?
Patent 7,816,396 protects CUVPOSA and is included in one NDA.
Summary for Patent: 7,816,396
| Title: | Method for increasing the bioavailability of glycopyrrolate |
| Abstract: | The invention relates to a method of treating sialorrhea in a human patient, which comprises orally administering glycopyrrolate in a liquid solution to the human patient under fasted conditions. |
| Inventor(s): | Roberts; Alan (Woodstock, GA), Venkataraman; Balaji (Alpharetta, GA) |
| Assignee: | Shionogi Pharma, Inc. (Atlanta, GA) |
| Application Number: | 12/648,068 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 7,816,396
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merz Pharms | CUVPOSA | glycopyrrolate | SOLUTION;ORAL | 022571-001 | Jul 28, 2010 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA)IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 7,816,396
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,091,236 | Method for increasing the bioavailability of glycopyrrolate | ➤ Sign Up |
| 7,638,552 | Method for increasing the bioavailability of glycopyrrolate | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
